Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design Starling, Naureen; Elez, Elena; Strickler, John H.; Benson, Al; Oki, Eiji; Mendez, Guillermo; Ferreiro, Reyes; Lau, Yong Loo; Kawazoe, Akihito; Tian, Min; Campbell, Nicole; Cohen, Daniel N.; Edwards, Ken; Stjepanovic, Neda; Seligmann, Jenny F. Share Save
Share Save
Share Save
Share Save
Share Save
Precision Oncology: A Global Perspective on Implementation and Policy Development Horgan, Denis; Tanner, Marcel; Aggarwal, Charu; Thomas, David; Grover, Surbhi; Basel-Salmon, Lina; Dienstmann, Rodrigo; Tan, Tira Jing Ying; Park, Woong-Yang; Abu Rasheed, Hadi Mohamad; Siu, Lillian L.; Ma, Brigette; Ortiz-Lopez, Rocio; van den Bulcke, Marc; Taucher, Silvia Castillo; Ferris, Andrea; Starling, Naureen; Malapelle, Umberto; Longshore, John; Saldana, Hugo Alberto Barrera; Subbiah, Vivek Share Save
Maintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial Gordon, A.; Rajan, Z.; Fong, C. Y. K.; Peckitt, C.; Satchwell, L.; Cromarty, S.; Kidd, S.; Piadel, K.; Leamon, B.; Zhitkov, O.; Davidson, M.; Thompson, J.; Maisey, N. R.; Darby, S.; Waddell, T. S.; Morgan, C.; Bradshaw, A.; Starling, N.; Chau, I.; Cunningham, D. Share Save
Share Save
Maintenance durvalumab after fi rst-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study Fong, C.; Patel, B.; Peckitt, C.; Bourmpaki, E.; Satchwell, L.; Cromarty, S.; Kidd, S.; von Loga, K.; Uhlik, M.; Begum, R.; Rana, T.; Waddell, T.; Darby, S.; Bradshaw, A.; Roques, T.; Morgan, C.; Rees, C.; Herbertson, R.; Das, P.; Thompson, C.; Hewish, M.; Petty, R.; Thistlethwaite, F.; Rao, S.; Starling, N.; Chau, I.; Cunningham, D. Share Save
Share Save
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study Slater, Susanna; Bryant, Annette; Aresu, Maria; Begum, Ruwaida; Chen, Hsiang-Chi; Peckitt, Clare; Lazaro-Alcausi, Retchel; Carter, Paul; Anandappa, Gayathri; Khakoo, Shelize; Melcher, Lucinda; Potter, Vanessa; Marti, Francisca M.; Huang, Joesph; Branagan, Graham; George, Nicol; Abulafi, Muti; Duff, Sarah; Raja, Ashraf; Gupta, Ashish; West, Nicholas; Bucheit, Leslie; Rich, Thereasa; Chau, Ian; Cunningham, David; Starling, Naureen Share Save
Immunological markers of pathological and clinical and outcomes in mismatch repair deficient (MMRd) colorectal cancer (CRC) Challoner, B. R.; Slater, S. C.; Sansano, H. B.; Aresu, M.; Bryant, A.; Chen, H-C.; Begum, R.; Rana, T.; Zhitkov, O.; Leamon, B.; Barber, L. J.; Peckitt, C.; Chau, I.; Starling, N.; Cunningham, D.; Gerlinger, M. Share Save
Predictive biomarkers and protein specific mismatch repair (MMR) loss in gastrointestinal (GI) tumours on immune checkpoint inhibitors (ICI): Correlation with survival Le, H. M. L.; Paiva, R. V. D. S.; Farag, S.; Dadouli, K.; Ntellas, P.; Cunningham, D.; Starling, N.; Rao, S.; Fribbens, C.; Chau, I. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
